Pact with the devil: alemtuzumab therapy, immune suppression and infectious complications in chronic lymphocytic leukemia. [electronic resource]
Producer: 20140616Description: 92-5 p. digitalISSN:- 0048-7848
- Adult
- Alemtuzumab
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antitubercular Agents -- therapeutic use
- Humans
- Immunocompromised Host
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Splenectomy
- Treatment Outcome
- Tuberculosis, Miliary -- diagnosis
- Tuberculosis, Splenic -- diagnosis
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.